Search

everythinglearnresearchcommunity

for

Search:↓

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

People with hypohidrotic ectodermal dysplasia are more likely to experience long-term fatigue and hair loss after COVID-19.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

Your lifestyle and health can affect your chances of getting COVID-19; not enough sleep, lots of exercise, and hair loss can increase risk, while washing hands, eating fruit daily, and taking vitamins A and C can lower it.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Men may be more vulnerable to severe COVID-19 due to genetic and hormonal factors, but more research is needed.

A prostate cancer drug can lower the levels of a protein that the coronavirus uses to enter lung cells.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

Insulin resistance linked to obesity may increase COVID-19 severity.

Natural compounds, especially Withaferin-A, may help treat post-COVID-19 complications, but some may have side effects.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Certain drugs like Dutasteride and Finasteride might help fight SARS-CoV-2 by increasing levels of a steroid called DHEA, which can protect the heart and increase nitric oxide to counteract the virus.

Losartan may help treat Postural Orthostatic Tachycardia Syndrome (POTS) symptoms.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

Hair loss doesn't affect COVID-19 severity.

The virus was not found in the semen and urine of a man who tested positive for COVID-19.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Androgen deprivation therapy might be better for preventing COVID-19 than treating it.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Anabolic steroid users may face higher risk of severe COVID-19.